Company-led study finds those who who got medication for 5 days improved 65%, while there was no proven difference when getting it for 10 days; more details to be published

Researchers estimate death rate slightly higher among those taking hydroxychloroquine; separate study on remdesivir suggests benefit in treating COVID-19

Pharmaceutical company developing leading treatment for coronavirus; ClearSky cybersecurity outfit says Iran-connected hackers targeting COVID-19 researchers, including in Israel

Health Ministry’s Asher Shalmon predicts future 'spike' in cases, admits 'compromises' and 'confusion' in management of economy reopening

FDA last week gave emergency approval to medicine produced by Gilead Sciences; it is believed to shorten illness time in some, but effect on mortality rates still unclear

Defense Department working on new blood-based screening that identifies body's immune response, may find illness 4 days earlier than current swab tests

Regulations gradually eased amid warnings from health experts that a second wave of infections could hit unless testing for the virus is expanded dramatically

In preliminary US trial Gilead Science’s remdesivir shortens recovery time by 4 days; cleared for use for hospitalized patients with 'severe disease'

Some doctors want to start administering remdesivir -- touted by Fauci -- immediately, but others are more cautious

Gilead Sciences says government medical agency to soon present results of trial testing remdesivir, which has been used at least once in Israel to treat virus